Achaogen Appoints Kenneth J. Hillan, M.B. Ch.B., to Chief Medical Officer
3/23/2011 11:07:51 AM
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Achaogen, Inc., a biopharmaceutical company discovering and developing antibiotics for the treatment of life-threatening, multi-drug resistant (MDR) bacterial infections, today announced the hiring of Kenneth J. Hillan, M.B. Ch.B., as chief medical officer. Dr. Hillan will fill a key role on the company’s senior leadership team with responsibility for all clinical development and regulatory activities as well as pipeline strategy.
comments powered by